| Primary |
| Benign Prostatic Hyperplasia |
38.6% |
| Prostate Cancer |
22.5% |
| Product Used For Unknown Indication |
10.9% |
| Hypertension |
6.0% |
| Neoplasm Prophylaxis |
5.4% |
| Depression |
3.2% |
| Drug Use For Unknown Indication |
2.8% |
| Constipation |
1.6% |
| Alopecia |
0.8% |
| Anticoagulant Therapy |
0.8% |
| Atrial Fibrillation |
0.8% |
| Blood Pressure |
0.8% |
| Diabetes Mellitus |
0.8% |
| Gastritis |
0.8% |
| Prophylaxis |
0.8% |
| Routine Health Maintenance |
0.8% |
| Blood Cholesterol Increased |
0.6% |
| Dizziness |
0.6% |
| Glaucoma |
0.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.6% |
|
| Hepatic Function Abnormal |
12.0% |
| Myocardial Infarction |
8.0% |
| Aspartate Aminotransferase Increased |
7.0% |
| Coronary Artery Disease |
7.0% |
| Liver Function Test Abnormal |
7.0% |
| Pancreatitis |
5.0% |
| Pulmonary Oedema |
5.0% |
| Rectal Cancer |
5.0% |
| Blood Lactate Dehydrogenase Increased |
4.0% |
| Chest Pain |
4.0% |
| Pancytopenia |
4.0% |
| Pulmonary Embolism |
4.0% |
| Syncope |
4.0% |
| Urinary Incontinence |
4.0% |
| Vision Blurred |
4.0% |
| Visual Acuity Reduced |
4.0% |
| Alanine Aminotransferase Increased |
3.0% |
| Blood Creatine Phosphokinase Increased |
3.0% |
| Blood Pressure Increased |
3.0% |
| Cerebrovascular Accident |
3.0% |
|
| Secondary |
| Benign Prostatic Hyperplasia |
21.8% |
| Prostate Cancer Metastatic |
20.2% |
| Drug Use For Unknown Indication |
14.3% |
| Product Used For Unknown Indication |
9.2% |
| Multiple Myeloma |
3.8% |
| Prophylaxis |
3.8% |
| Prostate Cancer |
3.4% |
| Alopecia |
2.9% |
| Constipation Prophylaxis |
2.5% |
| Infection Prophylaxis |
2.5% |
| Respiratory Tract Infection |
2.5% |
| Hypertension |
2.1% |
| Depression |
1.7% |
| Urine Flow Decreased |
1.7% |
| Abdominal Distension |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Blood Pressure |
1.3% |
| Calcium Deficiency |
1.3% |
| Fluid Retention |
1.3% |
| Insomnia |
1.3% |
|
| Lipase Increased |
9.8% |
| Medication Error |
7.8% |
| Angina Unstable |
5.9% |
| Major Depression |
5.9% |
| Pancreatitis Acute |
5.9% |
| Platelet Count Decreased |
5.9% |
| Renal Mass |
5.9% |
| Syncope |
5.9% |
| Urinary Tract Infection |
5.9% |
| Completed Suicide |
3.9% |
| Haematochezia |
3.9% |
| Pitting Oedema |
3.9% |
| Pneumonia |
3.9% |
| Prostate Cancer |
3.9% |
| Renal Failure Acute |
3.9% |
| Renal Impairment |
3.9% |
| Thrombocytopenia |
3.9% |
| Transient Ischaemic Attack |
3.9% |
| Tumour Necrosis |
3.9% |
| Aspartate Aminotransferase Increased |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.1% |
| Drug Use For Unknown Indication |
13.4% |
| Hypertension |
9.3% |
| Benign Prostatic Hyperplasia |
8.7% |
| Prophylaxis |
4.8% |
| Constipation |
3.1% |
| Diabetes Mellitus |
3.1% |
| Atrial Fibrillation |
2.7% |
| Pain |
2.7% |
| Type 2 Diabetes Mellitus |
2.4% |
| Hypercholesterolaemia |
2.2% |
| Prostate Cancer |
2.2% |
| Colorectal Cancer |
2.1% |
| Back Pain |
2.0% |
| Cardiovascular Disorder |
1.9% |
| Hyperlipidaemia |
1.9% |
| Prostatomegaly |
1.7% |
| Haemorrhoidal Haemorrhage |
1.6% |
| Insomnia |
1.6% |
| Pneumonia |
1.5% |
|
| Death |
8.4% |
| Flushing |
8.4% |
| Drug Interaction |
6.1% |
| Interstitial Lung Disease |
6.1% |
| Pancreatic Carcinoma |
6.1% |
| Tremor |
6.1% |
| Thrombocytopenia |
5.3% |
| Vomiting |
5.3% |
| Dizziness |
4.6% |
| Renal Failure Acute |
4.6% |
| Respiratory Failure |
4.6% |
| Rhabdomyolysis |
4.6% |
| Violence-related Symptom |
4.6% |
| Pneumonia |
3.8% |
| Pollakiuria |
3.8% |
| Prostate Cancer |
3.8% |
| Sepsis |
3.8% |
| Transaminases Increased |
3.8% |
| Atrial Fibrillation |
3.1% |
| Diarrhoea |
3.1% |
|
